CFO4Life Group’s Enbridge ENB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $547K | Sell |
10,091
-19
| -0.2% | -$1.04K | 0.07% | 127 |
|
|
2026
Q1 | $547K | Sell |
10,110
-3,221
| -24% | -$164K | 0.08% | 116 |
|
|
2025
Q4 | $638K | Buy |
13,331
+7
| +0.1% | +$334 | 0.09% | 105 |
|
|
2025
Q3 | $672K | Sell |
13,324
-133
| -1% | -$6.26K | 0.1% | 105 |
|
|
2025
Q2 | $610K | Sell |
13,457
-1,437
| -10% | -$65.2K | 0.1% | 112 |
|
|
2025
Q1 | $660K | Sell |
14,894
-1,726
| -10% | -$75.1K | 0.11% | 94 |
|
|
2024
Q4 | $705K | Hold |
16,620
| – | – | 0.12% | 94 |
|
|
2024
Q3 | $675K | Sell |
16,620
-137
| -0.8% | -$5.28K | 0.12% | 102 |
|
|
2024
Q2 | $596K | Buy |
16,757
+494
| +3% | +$17.6K | 0.11% | 101 |
|
|
2024
Q1 | $588K | Hold |
16,263
| – | – | 0.11% | 104 |
|
|
2023
Q4 | $586K | Sell |
16,263
-299
| -2% | -$10.1K | 0.11% | 104 |
|
|
2023
Q3 | $551K | Sell |
16,562
-1,052
| -6% | -$37.3K | 0.13% | 96 |
|
|
2023
Q2 | $654K | Sell |
17,614
-281
| -2% | -$10.7K | 0.14% | 80 |
|
|
2023
Q1 | $683K | Sell |
17,895
-71
| -0.4% | -$2.79K | 0.16% | 74 |
|
|
2022
Q4 | $702K | Sell |
17,966
-2,880
| -14% | -$113K | 0.15% | 79 |
|
|
2022
Q3 | $773K | Buy |
20,846
+2,569
| +14% | +$108K | 0.21% | 54 |
|
|
2022
Q2 | $776K | Buy |
18,277
+204
| +1% | +$9.11K | 0.19% | 55 |
|
|
2022
Q1 | $833K | Buy |
18,073
+312
| +2% | +$13.4K | 0.17% | 60 |
|
|
2021
Q4 | $694K | Buy |
17,761
+558
| +3% | +$22.4K | 0.14% | 79 |
|
|
2021
Q3 | $685K | Buy |
17,203
+346
| +2% | +$13.6K | 0.16% | 70 |
|
|
2021
Q2 | $675K | Buy |
16,857
+75
| +0.4% | +$2.9K | 0.16% | 67 |
|
|
2021
Q1 | $611K | Sell |
16,782
-1,504
| -8% | -$52.9K | 0.15% | 73 |
|
|
2020
Q4 | $585K | Buy |
18,286
+685
| +4% | +$20.8K | 0.17% | 69 |
|
|
2020
Q3 | $514K | Buy |
17,601
+143
| +0.8% | +$4.5K | 0.17% | 64 |
|
|
2020
Q2 | $531K | Sell |
17,458
-673
| -4% | -$20.7K | 0.2% | 53 |
|
|
2020
Q1 | $527K | Buy |
18,131
+852
| +5% | +$31.6K | 0.28% | 49 |
|
|
2019
Q4 | $687K | Sell |
17,279
-212
| -1% | -$7.92K | 0.29% | 49 |
|
|
2019
Q3 | $614K | Buy |
17,491
+54
| +0.3% | +$1.87K | 0.28% | 51 |
|
|
2019
Q2 | $629K | Buy |
17,437
+1,361
| +8% | +$49.6K | 0.29% | 52 |
|
|
2019
Q1 | $583K | Sell |
16,076
-630
| -4% | -$22.7K | 0.27% | 56 |
|
|
2018
Q4 | $519K | Buy |
+16,706
| New | +$537K | 0.23% | 62 |
|
Other funds holding ENB
CFO4Life Group's ENB Position: Q2 2026 in Review
CFO4Life Group reduced its Enbridge (ENB) stake by 0.19% in Q2 2026, selling an estimated $1.04K and leaving 10,091 shares worth $547K. The position accounts for 0.07% of the portfolio, ranked #127.
CFO4Life Group first reported a position in ENB in Q4 2018 and has held it in 31 quarters since. The position peaked at $833K in Q1 2022. 1,519 funds tracked by Wall St. Rank hold ENB as of Q2 2026.
- CFO4Life Group held 10,091 shares of Enbridge worth $547K as of Q2 2026.
- CFO4Life Group sold 19 Enbridge shares in Q2 2026, an estimated $1.04K.
- Enbridge made up 0.07% of CFO4Life Group's portfolio in Q2 2026, its #127 holding.
- CFO4Life Group first reported a position in Enbridge in Q4 2018 and has held it in 31 quarters since.
- CFO4Life Group's Enbridge position peaked at $833K in Q1 2022.
- 1,519 funds tracked by Wall St. Rank held Enbridge as of Q2 2026.
Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.